A group of investors suggested reverse mergers, licensing strategies and oncology companies during a panel on how to fund a startup company in biotech or medtech. One investor said four forces were combining to make 2013 a great year for medtech.
Venture capital investment in the life sciences has fallen 39 percent over the past three years as the costly, lengthy process of getting approval for pharmaceuticals from the Food and Drug Administration has spurred companies to shift their investments to overseas markets in Europe and Asia. According to the survey of 150 venture capital firms, […]
This eBook provides actionable strategies, real-world best practices to help payers stay ahead in a value-based care environment.